Norway Savings Bank’s ResMed RMD Stock Holding History

Norway Savings Bank’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-125	Closed	-$26K	–	291
2022 Q2	$26K	Hold	125	–	–	0.01%	224
2022 Q1	$30K	Hold	125	–	–	0.01%	222
2021 Q4	$33K	Hold	125	–	–	0.01%	218
2021 Q3	$33K	Hold	125	–	–	0.02%	222
2021 Q2	$31K	Hold	125	–	–	0.02%	234
2021 Q1	$24K	Hold	125	–	–	0.01%	243
2020 Q4	$27K	Hold	125	–	–	0.02%	245
2020 Q3	$21K	Buy	+125	New	+$23.1K	0.01%	231

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Norway Savings Bank's RMD Position: Q3 2022 in Review

Norway Savings Bank sold out of ResMed (RMD) in Q3 2022, closing a stake of 125 shares — an estimated $26K sold.

Norway Savings Bank first reported a position in RMD in Q3 2020 and held it in 8 quarters. The position peaked at $33K in Q4 2021. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

Norway Savings Bank reported no remaining ResMed position as of Q3 2022 after selling out during the quarter.
Norway Savings Bank sold 125 ResMed shares in Q3 2022, an estimated $26K.
Norway Savings Bank first reported a position in ResMed in Q3 2020 and held it in 8 quarters.
Norway Savings Bank's ResMed position peaked at $33K in Q4 2021.
667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Norway Savings Bank's 13F filing for Q3 2022, filed 18 Oct 2022.